Vyome Holdings, Inc, a clinical-stage healthcare holding company, has entered into a Memorandum of Understanding with Embryyo Technologies to work together on opportunities in the expanding global market for AI-powered medical devices. This strategic collaboration aims to combine Vyome’s strong experience in the healthcare field with Embryyo’s expertise in advanced medical technologies. Together, they plan to explore, develop, and possibly bring to market smart devices that could change how diseases are treated and cared for.
Health Technology Insights: knownwell Expands with Second Clinic in Greater Boston
Krishna Gupta, Chairman of Vyome Holdings, commented on the partnership, stating, “Vyome’s goal is to work with the brightest minds addressing the largest healthcare markets along the US-India corridor and across our three main areas: pharma, AI, and medical devices. AI-enabled medical devices offer a major opportunity, and the Embryyo team, made up of graduates from Indian Institutes of Technology (IIT), has been active in this space for over a decade. We will be working with them to identify the specific projects we will focus on together.”
Embryyo Technologies, recognized for its development of innovative healthcare tools, views this collaboration as a step toward making a global impact. Nishant Kumar, Co-Founder and CEO of Embryyo Technologies, said, “We’re excited about this partnership with Vyome because we share a common vision. We’re currently developing a range of groundbreaking medical devices in areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome’s access to global capital markets and the U.S. healthcare system will help us speed up our mission to advance medicine and raise the standards of care worldwide.”
Health Technology Insights: ChiroTouch Launches Rheo: The First AI Assistant Purpose-Built for Chiropractors
The companies see this agreement as more than just a partnership. It reflects a shared commitment to pushing boundaries in healthcare innovation. The aim is not only to bring new medical devices to market but to do so in a way that integrates advanced technologies with practical, scalable healthcare solutions.
As part of their partnership, Vyome and Embryyo intend to organize a global innovation forum centered on AI-driven medical devices. This forum will bring together startups and healthcare companies operating in both the U.S. and India. While the current agreement is not binding, it represents a significant move toward establishing concrete initiatives that could influence the future of smart healthcare technologies in both markets.
Health Technology Insights: Aptarro and aiHealth Partner for AI-Powered Coding Automation
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
